Becoming a Biotech VC

Joining RA Capital in Boston to develop new biomedicines

Logo for RA Capital.
My Go/No Go essay about Nivien Therapeutics was republished in The Washington Post and catalyzed follow-up articles by John LaMattina in Forbes, Derek Lowe in Science, and an interview in Nature.

Principal at RA Capital, on the boards of 7 biotech companies. Founder/CEO of Nivien Therapeutics. Australian-American. 50 countries and counting.